Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE LevelsDavid Riddell, Peter H. Reinhart, Hua Zhou et al.|Journal of Neuroscience|2008Cited by 351
Begacestat (GSI-953): A Novel, Selective Thiophene Sulfonamide Inhibitor of Amyloid Precursor Protein γ-Secretase for the Treatment of Alzheimer’s DiseaseRobert Martone, J. Steven Jacobsen, Jane Z. Xu et al.|Journal of Pharmacology and Experimental Therapeutics|2009Cited by 157
Enhanced clearance of Aβ in brain by sustaining the plasmin proteolysis cascadeJ. Steven Jacobsen, Menelas N. Pangalos, Thomas A. Comery et al.|Proceedings of the National Academy of Sciences|2008Cited by 141
Discovery of Begacestat, a Notch-1-Sparing γ-Secretase Inhibitor for the Treatment of Alzheimer’s DiseaseScott C. Mayer, J. Steven Jacobsen, Anthony F. Kreft et al.|Journal of Medicinal Chemistry|2008Cited by 111
Design and synthesis of aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors with enhanced brain permeabilityMichael S. Malamas, Menelas N. Pangalos, Albert J. Robichaud et al.|Bioorganic & Medicinal Chemistry Letters|2010Cited by 52